Concepedia

Katja Issbrücker

KI

6

Publications

1.5K

Citations

6

H-Index

2002

Active since

Affiliations

Max Planck Institute for Heart and Lung Research(Current)

Philipps University of Marburg

Ludwig-Maximilians-Universität München

University of California San Diego

Helmholtz Centre for Infection Research

Katja Issbrücker is an author at Max Planck Institute for Heart and Lung Research specializing in angiogenesis, medicine, and cell biology.

Top concepts

Publications per year

2002–2003

6

Publications

6

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18

Andreas Rembert Koczulla, Georges von Degenfeld, Christian Kupatt et al. · Journal of Clinical Investigation · 2003 · 833 citations · Full text

VEGFR-1–Selective VEGF Homologue PlGF Is Arteriogenic

Frederic Pipp, Matthias Heil, Katja Issbrücker et al. · Circulation Research · 2003 · 313 citations · Full text

p38 MAP Kinase—a molecular switch between VEGF‐induced angiogenesis and vascular hyperpermeability

Katja Issbrücker, Hugo H. Marti, Stefan Hippenstiel et al. · The FASEB Journal · 2002 · 178 citations

, , +18

NAB2, a Corepressor of EGR-1, Inhibits Vascular Endothelial Growth Factor-mediated Gene Induction and Angiogenic Responses of Endothelial Cells

Markus Lucerna, Diana Mechtcheriakova, Alexandra Kadl et al. · Journal of Biological Chemistry · 2003 · 95 citations · Full text

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18

Andreas Rembert Koczulla, Georges von Degenfeld, Christian Kupatt et al. · Journal of Clinical Investigation · 2003 · 52 citations · Full text

Rows per page

1–5 of 6